GenVec Shareholders Sue Over Intrexon Merger
Gene therapy research company GenVec Inc. was hit by a putative class action Tuesday in Delaware federal court by shareholders who say the company's imminent acquisition by Intrexon Corp. gives them...To view the full article, register now.
Already a subscriber? Click here to view full article